Irinotecan |
Camptosar |
Irinotecan Systematic (IUPAC) name (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy- 3,14-dioxo1H-pyrano[3’,4’:6,7]-indolizino[1,2-b]quinolin- 9-yl-[1,4’bipiperidine]-1’-carboxylate Identifiers CAS number 100286-90-6 ATC code L01XX19 PubChem 3750 DrugBank APRD00579 Chemical data Formula C33H38N4O6 Mol. weight 586.678 g/mol 677.185 g/mol (hydrochloride) Pharmacokinetic data Bioavailability NA Metabolism Hepatic glucuronidation Half life 6 to 12 ...
Wikipedia - [full article]
Resources
- Camptosar (Drug Digest)
- Irinotecan (Drug Digest)
Irinotecan News Headlines
- ERBITUX® Phase III Study Meets Primary Endpoint In First-Line Treatment Of Metastatic Colorectal Cancer
MedicalNewsToday - Mon, 15 Jan 2007 08:00 EST
- New Data At ASCO Show CAMPTOSAR Is Key To Treating 1st Line Metastatic Colorectal Cancer
MedicalNewsToday - Tue, 06 Jun 2006 06:00 EST
- Metastatic Colorectal Cancer In Patients Who Have Failed Prior Chemotherapy - License Application For FDA Approval Of Panitumumab
MedicalNewsToday - Sun, 02 Apr 2006 11:00 EST
- Metastatic Colorectal Cancer - Phase 3 Clinical Trial of Panitumumab Therapy for First-Line Treatment
MedicalNewsToday - Sat, 30 Apr 2005 05:00 EST

Not Signed In -

